Cytomegalovirus (CMV) is the most common infection after organ transplantation and has a
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …

Cytomegalovirus (CMV) infection remains a significant complication after hematopoietic
stem cell transplantation (HSCT) and may have a deleterious impact on the overall outcome …

Cytomegalovirus (CMV) remains one of the most common infections after solid organ
transplantation, resulting in significant morbidity, graft loss, and occasional mortality …

Cytomegalovirus (CMV) is a ubiquitous DNA herpes virus that causes significant morbidity
and mortality in immunocompromised individuals. CMV retinitis is a potentially blinding …

The naive phenotype of cord blood (CB) T cells may reduce graft-versus-host disease after
umbilical cord blood transplantation, but this naivety and their low absolute numbers also …

RK Avery, FM Marty, L. Strasfeld, I. Lee, A. Arrieta, S. Chou, W. Tatarowicz, S. Villano. Oral
maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant …

Cytomegalovirus (CMV) infections are among the most common infections that occur
following solid organ transplantation. CMV disease ranges from asymptomatic viremia, to …

Background. Cytomegalovirus (CMV) viremia that is resistant or refractory to the standard
antiviral therapy still constitutes a major threat to high-risk transplant recipients. In addition …

Opinion statement In treating cytomegalovirus (CMV) infection, it is crucial to decide whether
one is treating pre-emptively or if one is treating established disease. Disease may be …

Cytomegalovirus (CMV) is an opportunistic pathogen associated with significant morbidity
and mortality in immunocompromised hosts. Antiviral agents specifically targeting CMV were …